Status:
RECRUITING
Improve New Learning and Memory in Individuals With Mild Cognitive Impairment
Lead Sponsor:
Kessler Foundation
Collaborating Sponsors:
University of Michigan
Michigan State University
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
The current study is a double-blind, placebo-control randomized clinical trial examining the efficacy of memory retraining in individuals with Mild Cognitive Impairment (MCI). Impairment in higher lev...
Eligibility Criteria
Inclusion
- 60 or older.
- read and speak English fluently.
- Research based diagnosis of Amnestic Mild Cognitive Impairment
Exclusion
- prior stroke or neurological injury/disease (i.e. traumatic brain injury, Multiple Sclerosis, or Stroke).
- history of significant psychiatric illness (for example, bipolar disorder, schizophrenia, or psychosis).
- significant alcohol or drug abuse history (inpatient treatment).
- Benzodiazepines and steroid use
Key Trial Info
Start Date :
June 28 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 1 2027
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT05396248
Start Date
June 28 2023
End Date
March 1 2027
Last Update
May 16 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Michigan
Ann Arbor, Michigan, United States, 48105
2
Kessler Foundation Research Center
West Orange, New Jersey, United States, 07052